Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
about
Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different EtiologiesTranscription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation.
P2860
Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@ast
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@en
type
label
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@ast
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@en
prefLabel
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@ast
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@en
P2093
P356
P1476
Thrombopoietin receptor (Mpl) ...... myeloproliferative disorders.
@en
P2093
Ebru Serinsöz
Guntram Büsche
Hans Kreipe
Jerome Schlué
Michael Mengel
Oliver Bock
P304
P356
10.1002/PATH.1558
P577
2004-05-01T00:00:00Z